Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5072410012 | Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5072411011 | Levocetirizine and montelukast only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Is a | Product containing levocetirizine and montelukast in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Has active ingredient | Montelukast | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Has active ingredient | Levocetirizine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Is a | Product containing only levocetirizine and montelukast (medicinal product) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely levocetirizine dihydrochloride 5 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Is a | True | Product containing only levocetirizine and montelukast in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR